Month: January 2019

Celgene, which is being bought by Bristol-Myers Squibb, reported a better-than-expected fourth-quarter profit on Thursday, driven mainly by higher sales of psoriasis drug Otezla. Bristol-Myers agreed to buy Celgene for about $74 billion earlier this month, a deal that will expand its pipeline of cancer drugs as the company goes head-to-head against rival Merck &
0 Comments
Super-wealthy investors are making some changes to their portfolios for 2019. They are increasing their cash holdings and reducing their equity exposure. They are also cutting back on some of their real estate investments and finding a “short-term solution” in fixed income, according to Michael Sonnenfeldt, founder of investment club Tiger 21. “There’s a lot
0 Comments
The last two times Amazon has reported quarterly results, revenue has fallen short of expectations. Now investors are facing the prospects of slowing growth at the e-commerce giant. Amazon is slated to announce fourth-quarter earnings after the bell on Thursday. Analysts surveyed by Refinitiv expect the company to report revenue growth of 18.8 percent from
0 Comments
The “Fast Money” traders shared their first moves for the market open. Tim Seymour was a buyer of the Mexico ETF. Steve Grasso was a buyer of General Electric. Dan Nathan was a buyer of PayPal. Guy Adami was a buyer of Sarepta Therapeutics. Trader disclosure: Tim Seymour is long AAPL, ACBFF, AMZA, ACB, APC,
0 Comments
For those of you shaking your head at your portfolio’s low yield, you can actually 2X or 3X your portfolio’s yield and improve your upside potential to boot using this strategy. And it’s actually simpler than traditional stock picking. Many income investors have mistakenly parked their capital in “safe” consumer staples like General Mills, Kimberly-Clark
0 Comments
Alibaba shares soared after the company reported market-beating earnings in the three months ended December, with investors content with a record amount of spending by the company in the 2018 calendar year, hoping that it will spur future growth. The Chinese e-commerce giant posted its slowest revenue growth since 2016 in its fiscal third quarter,
0 Comments
Shares of health insurer Anthem soared to a record high Wednesday after it announced plans to roll out its new pharmacy benefits management unit IngenioRx sooner than expected and issued earnings guidance for this year that also beat forecasts. “IngenioRx will improve our ability to integrate pharmacy benefits within our already strong medical and specialty
0 Comments
Wheels Up has hired bankers for “strategic initiatives” that could include acquisitions, the company’s CEO told CNBC. “We have hired advisors to assist us with our pursuit of strategic initiatives that include exploring acquisition opportunities and expansion of our digital platform,” Wheels Up CEO Kenny Dichter told CNBC in a statement Wednesday evening. “Our plan
0 Comments